Immunoexpression of epithelial membrane antigen in canine meningioma: Novel results for perspective considerations

Vet Comp Oncol. 2021 Mar;19(1):115-122. doi: 10.1111/vco.12648. Epub 2020 Sep 15.

Abstract

Epithelial membrane antigen (EMA) is one of the most widely used diagnostic immunohistochemical markers for human meningioma. To date, no published study on EMA expression in formalin-fixed paraffin-embedded (FFPE) tissue samples of canine meningioma is available. Here, we describe the results of an immunohistochemical study on 25 FFPE canine meningiomas using a monoclonal anti-human EMA antibody. All meningiomas showed positive staining for EMA with cytoplasmic pattern, in nine cases associated with membranous staining. Area and intensity of staining were highly variable among cases. No clear relationships between tumour subtype/grade and area/intensity of staining were found. However, epithelial-like patterns showed a higher affinity for EMA compared to the mesenchymal one. The present study provides the basis to explore the potential diagnostic application of this marker in canine meningioma. To investigate EMA expression in other central nervous system tumours of dogs are necessary to assess the specificity of this marker.

Keywords: EMA; MUC1; dog; epithelial membrane antigen; immunohistochemistry; meningioma.

Publication types

  • Multicenter Study

MeSH terms

  • Animals
  • Antibodies
  • Central Nervous System Neoplasms / metabolism
  • Central Nervous System Neoplasms / veterinary*
  • Dog Diseases
  • Dogs
  • Female
  • Gene Expression Regulation, Neoplastic / immunology
  • Immunohistochemistry
  • Male
  • Meningioma / veterinary*
  • Mucin-1 / genetics
  • Mucin-1 / metabolism*
  • Retrospective Studies

Substances

  • Antibodies
  • Mucin-1